AM 7

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

75 API Suppliers, 44 USDMF, 30 CEP/COS, 5 JDMF, 3 EU WC, 40 KDMF, 22 NDC API, 24 Listed Suppliers

DEVELOPMENTS

22 Drug(s) in Development

22 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Formulations

1272 Dossiers, 209 FDA Orange Book, 418 Europe, 101 Canada, 70 Australia, 205 South Africa, 269 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 125MG/5ML;EQ 31.25MG BASE/5ML, FOR SUSPENSION;ORAL - 250MG/5ML;EQ 62.5MG BASE/5ML, TABLET;ORAL - 875MG;EQ 125MG BASE, FOR SUSPENSION;ORAL - 200MG/5ML;EQ 28.5MG BASE/5ML, FOR SUSPENSION;ORAL - 400MG/5ML;EQ 57MG BASE/5ML, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 600MG/5ML;EQ 42.9MG BASE/5ML, CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 200MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 400MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 62.5MG BASE, TABLET, EXTENDED RELEASE;ORAL - 775MG, CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 125MG/5ML;EQ 31.25MG BASE/5ML
FOR SUSPENSION;ORAL - 250MG/5ML;EQ 62.5MG BASE/5ML
TABLET;ORAL - 875MG;EQ 125MG BASE
FOR SUSPENSION;ORAL - 200MG/5ML;EQ 28.5MG BASE/5ML
FOR SUSPENSION;ORAL - 400MG/5ML;EQ 57MG BASE/5ML
TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 600MG/5ML;EQ 42.9MG BASE/5ML
CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 200MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 400MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 62.5MG BASE
TABLET, EXTENDED RELEASE;ORAL - 775MG
CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 15 Kerry, 11 Roquette, 10 Corel Pharma Chem, 9 Sigachi Industries, 8 BASF, 8 Microlex e.U, 6 Seppic, 6 Lonza Capsugel, 6 Gangwal Chemicals, 6 Gangwal Healthcare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 Ideal Cures Pvt Ltd, 3 Actylis, 3 DFE Pharma, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Kima Chemical, 3 Prachin Chemical, 3 Vasa Pharmachem, 2 The Dow Chemical Company, 2 Pharmatrans-Sanaq, 2 Nomisma Healthcare, 2 Seqens, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Pharm-RX Chemical, 1 Finar, 1 Ingredion Pharma Solutions, 1 Qualicaps, 1 SPI Pharma, 1 ACG Worldwide, 1 Rochem International Inc

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 24 Controlled & Modified Release, 22 Fillers, Diluents & Binders, 17 Thickeners and Stabilizers, 16 Disintegrants & Superdisintegrants, 12 Direct Compression, 12 Lubricants & Glidants, 9 Granulation, 7 Topical, 7 Film Formers & Plasticizers, 6 Co-Processed Excipients, 5 Empty Capsules, 5 API Stability Enhancers, 5 Solubilizers, 4 Vegetarian Capsules, 4 Taste Masking, 3 Emulsifying Agents, 3 Chewable & Orodispersible Aids, 2 Coloring Agents, 2 Rheology Modifiers, 2 Parenteral